scholarly article | Q13442814 |
P2093 | author name string | Wei Qiao | |
Jinbo Yang | |||
Kenneth Aldape | |||
Krishna P Bhat | |||
Gregory N Fuller | |||
Oliver Bögler | |||
Ganesh Rao | |||
Waldemar Priebe | |||
Yuhui Yang | |||
Jun Wei | |||
Sherise D Ferguson | |||
Amy B Heimberger | |||
Ling-Yuan Kong | |||
Tiffany A Doucette | |||
P2860 | cites work | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 |
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins | Q28645718 | ||
Stat3 as an oncogene | Q29614606 | ||
Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 | ||
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...] | Q33247166 | ||
The transcriptional network for mesenchymal transformation of brain tumours. | Q33572162 | ||
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis | Q33951212 | ||
Glioma-associated cancer-initiating cells induce immunosuppression | Q34147415 | ||
miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis | Q34221665 | ||
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses | Q34393758 | ||
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice | Q35211546 | ||
STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells | Q35343534 | ||
Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma. | Q35388292 | ||
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma | Q35642059 | ||
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 | ||
Insulin-like growth factor binding protein 2 promotes glioma development and progression | Q35880328 | ||
Platelet-derived growth factor (PDGF) and glial tumorigenesis | Q36247732 | ||
Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response | Q36416744 | ||
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. | Q37020840 | ||
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. | Q39876494 | ||
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells | Q40416582 | ||
STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation | Q42814110 | ||
Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. | Q42823786 | ||
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. | Q48493738 | ||
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas | Q48540461 | ||
PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. | Q48791387 | ||
Necrosis as a prognostic factor in glioblastoma multiforme | Q49057512 | ||
Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system | Q81469233 | ||
P433 | issue | 9 | |
P304 | page(s) | 1136-1145 | |
P577 | publication date | 2012-06-29 | |
P1433 | published in | Neuro-Oncology | Q15724471 |
P1476 | title | Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma | |
P478 | volume | 14 |
Q64275042 | 5p and 3p Strands of miR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells |
Q39121242 | A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells. |
Q57297289 | Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial |
Q39143478 | Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling |
Q41082492 | Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation |
Q34276296 | Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer |
Q24338526 | EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma |
Q36184181 | GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways |
Q36328555 | Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. |
Q37435455 | Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas |
Q34062038 | JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma |
Q28544728 | JSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitro |
Q47129437 | Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. |
Q37536748 | MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling |
Q26830388 | NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age |
Q37297056 | NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma |
Q38621047 | Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection |
Q34793267 | Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells |
Q35815273 | Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma |
Q38599484 | Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy |
Q64236540 | STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma |
Q58716603 | STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription |
Q35091330 | Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis |
Q33761711 | Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma |
Q34062021 | Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas. |
Q88122800 | TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis |
Q47279032 | TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma. |
Q33887448 | Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy |
Q90540850 | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution |
Q37599312 | Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma |
Q55456739 | The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. |
Q37091110 | The controversial role of microglia in malignant gliomas |
Q38363102 | The role of STAT3 in tumor-mediated immune suppression |
Q64113627 | Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model |
Q42577764 | Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression |
Q90695585 | Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth |
Q37191655 | miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma |
Q37276897 | miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis |
Search more.